Cargando…
Mesenchymal stem/stromal cells in cancer therapy
The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the...
Autores principales: | Lan, Tianxia, Luo, Min, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596342/ https://www.ncbi.nlm.nih.gov/pubmed/34789315 http://dx.doi.org/10.1186/s13045-021-01208-w |
Ejemplares similares
-
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy
por: Lan, Tianxia, et al.
Publicado: (2022) -
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
por: Lan, Tianxia, et al.
Publicado: (2021) -
Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
por: Cammarota, Francesca, et al.
Publicado: (2016) -
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023) -
Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles?
por: Lan, Tianxia, et al.
Publicado: (2021)